DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema
Clinical trial NCT06004986 · RECRUITING
Trial details
- NCT number
- NCT06004986
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-14
- Primary completion
- 2025-10-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.